REFERENCES
- Beder L. B., Gunduz M., Ouchida M., Fukushima K., Gunduz E., et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab. Invest. 2003; 83(1)99–105, [INFOTRIEVE], [CSA]
- Huang X. P., Wei F., Liu X. Y., Xu X., Hu H., et al. Allelic loss on 13q in esophageal squamous cell carcinomas from northern China. Cancer Lett. 2002; 185(1)87–94, [INFOTRIEVE], [CROSSREF], [CSA]
- Girard L., Zöchbauer-Müller S., Virmani A. K., Gazdar A. F., Minna J. D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000; 60(17)4894–4906, [INFOTRIEVE], [CSA]
- Goeze A., Schluns K., Wolf G., Thasler Z., Petersen S. Petersen I Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J. Pathol. 2002; 196(1)8–16, [INFOTRIEVE], [CROSSREF], [CSA]
- Lin Y., Sheu J., Liu L., Chen C., Lee H., et al. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur. J. Cancer. 1999; 35(12)1730–1734, [INFOTRIEVE], [CROSSREF], [CSA]
- Wong C. M., Lee J. M., Lau T. C., Fan S. T., Ng I. O. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin. Cancer Res. 2002; 8(7)2266–2272, [INFOTRIEVE], [CSA]
- Hyytinen E. R., Frierson H. F., Jr, Boyd J. C., Chung L. W., Dong J. T. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Genes Chromosomes Cancer. 1999; 25(2)108–114, [INFOTRIEVE], [CROSSREF], [CSA]
- Yin Z., Spitz M. R., Babaian R. J., Strom S. S., Troncoso P., et al. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 1999; 18(52)7576–7583, [INFOTRIEVE], [CROSSREF], [CSA]
- Kaye F. J. Rb and cyclin dependent kinase pathways: defining a distinction between rb and p16 loss in lung cancer. Oncogene 2002; 21(45)6908–6914, [INFOTRIEVE], [CROSSREF], [CSA]
- Osada H., Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene. 2002; 21(48)7421–7434, [INFOTRIEVE], [CROSSREF], [CSA]
- Yokota J., Nishioka M., Tani M., Kohno T. Genetic alterations responsible for metastatic phenotypes of lung cancer cells. Clin. Exp. Metastasis. 2003; 20(3)189–193, [INFOTRIEVE], [CROSSREF], [CSA]
- Kuroki T., Fujiwara Y., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br. J. Cancer. 1995; 72(2)383–385, [INFOTRIEVE], [CSA]
- Katagiri T., Nakamura Y., Miki Y. Mutations in the brca2 gene in hepatocellular carcinomas. Cancer Res. 1996; 56(20)4575–4577, [INFOTRIEVE], [CSA]
- Kirkpatrick H., Waber P., Hoa-Thai T., Barnes R., Osborne-Lawrence S., et al. Infrequency of brca2 alterations in head and neck squamous cell carcinoma. Oncogene. 1997; 14(18)2189–2193, [INFOTRIEVE], [CROSSREF], [CSA]
- Gupta V. K., Schmidt A. P., Pashia M. E., Sunwoo J. B., Scholnick S. B. Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int. J. Cancer. 1999; 84(5)453–457, [INFOTRIEVE], [CROSSREF], [CSA]
- Visakorpi T. Molecular genetics of prostate cancer. Annales Chirurgiae et Gynaecologiae. 1999; 88(1)11–16, [INFOTRIEVE], [CSA]
- Gorgoulis V. G., Kotsinas A., Zacharatos P., Mariatos G., Liloglou T., et al. Association of allelic imbalance at locus D13S171 (brca2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma. Cancer. 2000; 89(9)1933–1945, [INFOTRIEVE], [CROSSREF], [CSA]
- Chen C., Frierson H. F., Jr., Haggerty P. F., Theodorescu D., Gregory C. W., Dong J. T. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas. Genomics. 2001; 77(3)135–144, [INFOTRIEVE], [CROSSREF], [CSA]
- Kimura M., Okano Y. Molecular cloning and characterization of the human NIMA-related protein kinase 3 gene (nek3). Cytogenet. Cell Genet. 2001; 95(3–4)177–182, [INFOTRIEVE], [CROSSREF], [CSA]
- Gerstein A. V., Almeida T. A., Zhao G., Chess E., Shih I. M., et al. Apc/ctnnb1 (β-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer. 2002; 34(1)9–16, [INFOTRIEVE], [CROSSREF], [CSA]
- Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997; 25(24)4876–4882, [INFOTRIEVE], [CROSSREF], [CSA]
- Gervois P., Torra I P, Chinetti G., Grotzinger T., Dubois G., et al. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol. 1999; 13(9)1535–1549, [INFOTRIEVE], [CROSSREF], [CSA]
- Kawai N., Shimada M., Kawahara H., Satoh N., Yokosawa H. Regulation of ascidian Rel by its alternative splice variant. Eur. J. Biochem. 2003; 270(22)4459–4468, [INFOTRIEVE], [CROSSREF], [CSA]